Team Imagine

Martin Shkreli
Shkreli testifying before the House Committee on Oversight and Government Reform, 2016
Born	(1983-03-17) March 17, 1983 (age 34) Brooklyn, New York, U.S.
Nationality	American
Alma mater	Baruch College
Occupation	Co-founder of MSMB Capital Management, Co-founder and former CEO of Retrophin Founder and former CEO of Turing Pharmaceuticals.
Known for	Turing Pharmaceuticals; Retrophin
Net worth	US$70 million (June 2017)
Criminal charge	Securities fraud
Criminal status	Convicted

Martin Shkreli (/ˈʃkrɛli/, born March 17, 1983) is an American businessman, former hedge fund manager, and convicted felon. He is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare; co-founder and former chief executive officer (CEO) of the biotechnology firm Retrophin; and founder and former CEO of Turing Pharmaceuticals. Shkreli is also the CEO of start-up software company Gödel Systems, which he founded in August 2016.

In September 2015, Shkreli received widespread criticism when Turing obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price by a factor of 56 (from US$13.5 to US$750 per pill), leading him to be referred to as "the most hated man in America" and "Pharma Bro".

In December 2015, Shkreli was arrested by the FBI after being indicted on federal charges of securities fraud. He subsequently resigned as CEO of Turing Pharmaceuticals and was replaced by the company's board chairman, Ron Tilles. Shkreli was convicted of two counts of securities fraud and one count of conspiring to commit securities fraud in August 2017.

Shkreli was born in Coney Island Hospital, Brooklyn. His parents are Albanian immigrants from Montenegro who worked as janitors. He, his two sisters, and his brother grew up in a working-class community in Sheepshead Bay, Brooklyn. Shkreli was raised Catholic and attended Sunday school as a child.